Search research articles
Contact Us
Filters
Showing results (741-750 of 791) with videos related to
Page
of 80
Sort By:
Annals of the Rheumatic Diseases
|
August 10, 2010
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice
M C van der Goes, J W G Jacobs, M Boers, et al.
The Journal of Rheumatology
|
April 5, 2007
Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis
Johannes W G Jacobs, Ron N J de Nijs, Willem F Lems, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
June 15, 2007
[Alendronate more effective than alfacalcidol in the prevention of osteoporosis in patients with rheumatic disease who are starting glucocorticoid therapy]
R N J de Nijs, J W G Jacobs, W F Lems, et al.
Annals of the Rheumatic Diseases
|
September 9, 2018
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey
Nadia M T Roodenrijs, Maria J H de Hair, Marlies C van der Goes, et al.
Nature Neuroscience
|
September 27, 2025
Hormonal milieu influences whole-brain structural dynamics across the menstrual cycle using dense sampling in multiple individuals
Carina Heller, Daniel Güllmar, Lejla Colic, et al.
Analytical Biochemistry
|
May 24, 2005
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform
Esther M G Jacobs, Jan C M Hendriks, Berry L J H van Tits, et al.
The New England Journal of Medicine
|
August 18, 2006
Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
Ron N J de Nijs, Johannes W G Jacobs, Willem F Lems, et al.
Annals of the Rheumatic Diseases
|
July 31, 2007
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
J N Hoes, J W G Jacobs, M Boers, et al.
Journal of the American Heart Association
|
May 25, 2021
CAVA (Ultrasound-Accelerated Catheter-Directed Thrombolysis on Preventing Post-Thrombotic Syndrome) Trial: Long-Term Follow-Up Results
Pascale Notten, André A E A de Smet, Lidwine W Tick, et al.
Rheumatology (Oxford, England)
|
December 21, 2019
Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate
Maxime M A Verhoeven, Janneke Tekstra, Paco M J Welsing, et al.
Page
of 80
Search research articles
Search
Showing results (741-750 of 791) with videos related to
Sort By:
Page
of 80
Annals of the Rheumatic Diseases
|
August 10, 2010
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice
M C van der Goes, J W G Jacobs, M Boers, et al.
The Journal of Rheumatology
|
April 5, 2007
Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis
Johannes W G Jacobs, Ron N J de Nijs, Willem F Lems, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
June 15, 2007
[Alendronate more effective than alfacalcidol in the prevention of osteoporosis in patients with rheumatic disease who are starting glucocorticoid therapy]
R N J de Nijs, J W G Jacobs, W F Lems, et al.
Annals of the Rheumatic Diseases
|
September 9, 2018
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey
Nadia M T Roodenrijs, Maria J H de Hair, Marlies C van der Goes, et al.
Nature Neuroscience
|
September 27, 2025
Hormonal milieu influences whole-brain structural dynamics across the menstrual cycle using dense sampling in multiple individuals
Carina Heller, Daniel Güllmar, Lejla Colic, et al.
Analytical Biochemistry
|
May 24, 2005
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform
Esther M G Jacobs, Jan C M Hendriks, Berry L J H van Tits, et al.
The New England Journal of Medicine
|
August 18, 2006
Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis
Ron N J de Nijs, Johannes W G Jacobs, Willem F Lems, et al.
Annals of the Rheumatic Diseases
|
July 31, 2007
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
J N Hoes, J W G Jacobs, M Boers, et al.
Journal of the American Heart Association
|
May 25, 2021
CAVA (Ultrasound-Accelerated Catheter-Directed Thrombolysis on Preventing Post-Thrombotic Syndrome) Trial: Long-Term Follow-Up Results
Pascale Notten, André A E A de Smet, Lidwine W Tick, et al.
Rheumatology (Oxford, England)
|
December 21, 2019
Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate
Maxime M A Verhoeven, Janneke Tekstra, Paco M J Welsing, et al.
Page
of 80